NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.40
-0.57 (-3.36%)
At close: Dec 5, 2025, 4:00 PM EST
16.32
-0.08 (-0.49%)
After-hours: Dec 5, 2025, 7:22 PM EST
NeuroPace Revenue
NeuroPace had revenue of $27.35M in the quarter ending September 30, 2025, with 29.89% growth. This brings the company's revenue in the last twelve months to $94.86M, up 24.08% year-over-year. In the year 2024, NeuroPace had annual revenue of $79.91M with 22.14% growth.
Revenue (ttm)
$94.86M
Revenue Growth
+24.08%
P/S Ratio
5.51
Revenue / Employee
$515,565
Employees
184
Market Cap
546.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79.91M | 14.48M | 22.14% |
| Dec 31, 2023 | 65.42M | 19.90M | 43.72% |
| Dec 31, 2022 | 45.52M | 337.00K | 0.75% |
| Dec 31, 2021 | 45.18M | 4.05M | 9.83% |
| Dec 31, 2020 | 41.14M | 4.17M | 11.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NPCE News
- 4 days ago - NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting - Business Wire
- 12 days ago - NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services - Business Wire
- 4 weeks ago - NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - Business Wire
- 6 weeks ago - NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 - Business Wire
- 3 months ago - NeuroPace to Participate in Upcoming Healthcare Conferences - Business Wire
- 4 months ago - NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - GlobeNewsWire